
KERUIHK-0109

Lyophilized PowderProduct image
Weight Loss & Metabolic
Liraglutide
GMPKERUIHK-0109
GLP-1 receptor agonist with C16 fatty acid conjugation for extended half-life. Proven weight management therapy.
Product Specifications
- CAS Number
- 204656-20-2
- Catalog Purity
- ≥99.35%
- Form
- Lyophilized Powder
- Catalog Grade
- GMP
Product Details
Liraglutide specifications
Use the product name, catalog reference and available specifications below when discussing your requirements with our team.
- Product
- Liraglutide
- Catalog reference
- KERUIHK-0109
- CAS number
- 204656-20-2
- Category
- Weight Loss & Metabolic
- Physical form
- Lyophilized Powder
Latest reported batch: Liraglutide
Batch PB-2026-LIR-6154 · Oct 3, 2026
- Reported appearance
- White lyophilized powder
- Reported molecular weight / identity
- 3751.18 Da
- Analytical method
- RP-HPLC / ESI-MS
Reported analytical results
- HPLC Purity
- 99.23%Report specification: ≥99.0%
- Molecular Weight (MS)
- 3751.18 DaReport specification: 3751.20 ± 0.5 Da
- Amino Acid Analysis
- ConformsReport specification: Conforms to sequence
- Endotoxin (LAL)
- 0.27 EU/mgReport specification: < 1.0 EU/mg
Show 5 more test results
- Sterility (USP <71>)
- No growth observedReport specification: No evidence of microbial growth
- Residual Solvents
- < ICH Q3C limitsReport specification: ICH Q3C Class 2
- Water Content (KF)
- 5.10%Report specification: ≤ 8.0%
- Fatty Acid Conjugation
- ConformsReport specification: C16 fatty acid confirmed
- Peptide Content (AAA)
- 95.85%Report specification: ≥95.0%
Batch Documentation
Certificates of Analysis
Open a batch below to view its full report in our COA library, including available analytical attachments and PDF download.
Show 3 earlier reports
Product Inquiry
Request a Liraglutide quotation
We synthesize any sequence at any scale — from milligram research quantities to multi-kilogram commercial batches. OEM, private label, and GMP manufacturing available. Response within 24 hours.



